Pharmaceutical Industry Trends: Mergers and Acquisitions in Focus

In recent years, the pharmaceutical industry in France has seen a surge in mergers and acquisitions. With the challenges posed by the COVID-19 pandemic, pharmaceutical companies are looking at reorganization, optimization, and performance in new ways, leading to an increase in M&A operations.

These mergers offer opportunities for growth by expanding product portfolios, acquiring new technologies, and entering innovative markets. Industry players are finding themselves with a more unified profile as a result of these strategic moves.

One of the world’s leading human health biopharmaceutical companies embarked on a transformation program to optimize IT-related costs as part of its strategic plan. The goal was to explore opportunities for growth through M&A operations. To achieve this, the company partnered with Wavestone to standardize and industrialize its activities related to mergers, acquisitions, and divestitures.

Wavestone faced three key challenges in this collaboration:

1. Consolidating and standardizing practices and know-how internally and with external partners
2. Developing an end-to-end methodology for M&A projects
3. Industrializing activities and processes related to mergers, acquisitions, and divestitures

By working closely with the client, Wavestone developed a methodological guide to manage mergers, acquisitions, divestitures, and international growth programs. This included defining M&A phases, establishing governance models, and creating templates for executing activities in each phase of M&A operations.

The methodological guide went through an iterative process to ensure continuous improvement. Training modules were created to help participants understand and implement the guide effectively. Workshops and webinars were organized to illustrate the methodology with real-life cases and scenarios.

Since 2011, Wavestone has been supporting companies in various industries with their M&A and transformation programs. Their expertise in mergers, acquisitions, divestitures, and joint ventures has helped companies navigate complex strategic and organizational challenges.